Photo taken from FDA Oncology/X
Jul 3, 2024, 04:18
FDA and WHOSTP discuss increasing clinical trials access and lowering barriers to participation
FDA Oncology shared on X:
“FDA Oncology Center’s Paul Kluetz, Rick Pazdur, Donna Rivera attended the White House Office of Science & Technology Policy Clinical Trials Forum yesterday to meet with stakeholders to discuss increasing clinical trials access and lowering barriers to participation to improve health outcomes.”
Source: FDA Oncology/X
.